Reprint from Employee Benefit News by Deanna Cuadra
(ATLANTA, GA) – December 5th, 2022 As hospitals witness a surge of COVID-19, flu and respiratory syncytial virus (RSV) cases this winter, workforces may experience higher rates […]
November 21, 2022
Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID® COVID-19 Rapid Antigen Test.
An independent evaluation by the National Institutes of Health (NIH) RADx Variant Task Force has determined that the INDICAID® test detects the […]
(ATLANTA, GA) – The 2022 YSC Tour de Pink Lisa J. Frank Memorial Ride is a bicycle ride along the Jersey Shore that begins just outside of Long Branch, NJ . The ride amplifies the unique experience of young adults living with breast cancer and […]
(ATLANTA, GA) – PHASE Scientific, a health diagnostics innovator and maker of INDICAID COVID-19 Rapid Antigen Tests, and BCalifornia, a family-owned and operated business dedicated to the health and wellness of all communities, announced that the […]
(ATLANTA, GA) – Despite Americans’ most optimistic sentiments, COVID-19 is here to stay and so is its impact on employee health and absenteeism. PHASE Scientific Americas (PHASE) is a health diagnostics innovator and maker of INDICAID Rapid Antigen Tests. National Association […]
As stated by the covid.gov site:
“Ordering through this program will be suspended on Friday, September 2 because Congress hasn’t provided additional funding to replenish the nation’s stockpile of tests.”
While you are out enjoying life, including […]
While the recent surges of current COVID-19 variants are not driving high levels of hospitalization and death, the persistent, circulating virus continues to affect employees and spike absenteeism across businesses of all sizes. The impact is serious, affecting not only day-to-day operations and productivity […]
A virus that shows no signs of disappearing, variants that are adept at dodging the body’s defenses, and waves of infections two, maybe three times a year — this may be the future of Covid-19, some scientists now […]
(ATLANTA, GA) – July 27, 2022 – PHASE Scientific Americas (PHASE Scientific), a high-growth biotech company, announced that it has donated 2,000 of its FDA EUA-approved INDICAID® COVID-19 Rapid Antigen At-Home Test (INDICAID® OTC) to Atlanta Public Schools for […]
(Garden Grove, CA) – July 8, 2022 – PHASE Scientific Americas (PHASE Scientific), a high-growth biotech company, announced that it has donated 4,300 of its approved INDICAID® COVID-19 Rapid Antigen At-Home Test (INDICAID® OTC) to […]
